Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

New bone cutting technology from Finnish startup Surgify that prevents severe complications gets first surgical use

Surgify’s innovative surgical cutting technology has been taken into use at Helsinki University Hospital in October 2021. The technology speeds up the surgeon’s work, increases the safety and accuracy of surgery, and protects patients’ lives.Finnish startup Surgify  that recently launched an all-new and innovative surgical technology which allows surgeons to perform surgical operations on bones faster and safer has seen its first use cases on patients. Surgify’s flagship cutting technology is a result of diligent development work. The first surgeries were

Microsoft Flight Simulator Integrates Tobii's Eye and Head Tracking Technologies to Enhance Gaming Immersion

Tobii, the global leader in eye tracking and pioneer of attention computing, confirms Microsoft implemented support of Tobii Eye Tracker 5 and Tobii Horizon in Flight Simulator. After popular demand from the gaming community, the Tobii's eye and head tracking features will make the award-winning game more immersive for players.  Tobii Eye Tracker 5, engineered for PC gamers, translates the player's eye and head movements into data to enable new levels of game control, game analytics, and streaming. For games like Flight Simulator, where situational awareness makes all the difference, the

Offering of New Share in Relesys A/S was successfully completed – The Offering received subscription for DKK 221 Million (oversubscribed by 167%)

Relesys A/S | Company Announcement NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL This announcement does not constitute an offering circular, prospectus or other offer document as defined by Regulation (EU) No. 2017/1129 of 14 June 2017 and nothing herein shall be construed as an offering of securities. No one should purchase or subscribe for any securities in Relesys A/S ("Relesys" or the "Company") except on

BioStock: Elicera Therapeutics keeps strong momentum after IPO

Since its successful IPO on the Nasdaq First North Growth Market in June, Elicera Therapeutics has been advancing with all four of its cancer cell therapy projects. During Q3, one of the key highlights for the company has been the presentation of preclinical Proof-of-Concept data with its patented iTANK platform for the optimisation of CAR T-cell therapies. Since the period, Elicera has entered a collaboration with German gene therapy CDMO BioNTech for Elicera’s ELC-401 project. BioStock takes a closer look.Read the article at biostock.se: https://www.biostock.se/en/2021/11/elicera-

Metsä Board minimises environmental impact of packaging with Dassault Systèmes’ simulation platform

Metsä Board Corporation press release 24.11.2021Metsä Board, the leading European producer of premium fresh fibre paperboards and part of Metsä Group, has successfully started to deploy Dassault Systèmes’ 3DEXPERIENCE platform in development and testing of packaging solutions at its Excellence Centre. With packaging simulation Metsä Board can notably speed up packaging development and reduce carbon footprint of packaging. Simulation enables 85% faster development compared to the traditional way of making multiple tests with physical prototypes. Simulation technologies help manage the

Norvik Hf (“Norvik”) sells 17 million shares in Bergs Timber AB (publ) (“Bergs”) to a number of institutional investors

In May 2018, Norvik became the largest shareholder in Bergs (BRG B) as a result of Bergs acquisition of Norvik’s businesses in the Baltics and the UK. Bergs today has a revenue of about SEK 3 billion with strong result and financial position. Bergs has a decentralised business model and presented a new strategy in early 2021 with a clear ambition for growth through investments and acquisitions.In 2018, Norvik declared the intention to reduce its shareholding in Bergs to increase the free float and widen the ownership structure. Norvik has investigated the capital market and there has been a

NeoDynamics appoints Aaron Wong as CFO

The medtech company NeoDynamics AB has appointed Aaron Wong as CFO. Aaron Wong most recently comes from a similar position at the medtech company ADDvise Group AB listed on Nasdaq First North. He will assume the new position on February 1, 2022. Aaron Wong has extensive experience from the industry, financial markets and transactions, which fits in well with the development phase that NeoDynamics is entering. He has previously worked in financial roles at Johnson & Johnson and Informa Group, among others. Aaron Wong holds a BA in Accounting & Finance from De Montford University in

Registration of share capital reduction

Reference is made to the resolution by the general meeting on 30 September 2021 where a resolution was passed to reduce the Company's share capital by cancellation of treasury shares. The share capital reduction has now been registered with the Norwegian Register of Business Enterprises, and the new registered share capital of the Company is NOK 2,245,994.54, and the total share count is 112,299,727 each having a par value of NOK 0.02. Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com

Sleep Cycle recruits Chief Human Resources Officer and extends executive management team

Sleep Cycle has recruited Cecilia Mikkov to the position as Chief Human Resources Officer (“CHRO”) and member of the executive management team, starting in December. Cecilia has extensive leadership experience including responsibility for e.g. staff, recruitments and organizational development in Swedish and International organizations. Cecilia has a degree in human resources management and most recently held a position within HR Center of Excellence with NetEnt.As a part of Sleep Cycles growth plan, investments in people and product development have increased. Sleep Cycle will continue to

Interim Report 2021-07-01 – 2021-09-31

Financial Summery Third quarter (2021-07-01 – 2021-09-31) • Income amounted to TSEK 123 (204) • Result before tax amounted to TSEK -3 453 (-2 214) • Result per share was SEK -0,31 (-0,20) • Equity ratio amounted to 15 % (89 %) on 30 September 202 CEO Comments The third quarter of the year got off to a flying start as we already during the first week of the quarter sold an AcouWash system to our Japanese distributor Physio-Tech. Business activities during the summer continued to be characterized by the pandemic. However, we can state that interest in our technology is

NOTE – An invitation to Capital Markets Day 2021

NOTE is pleased to invite analysts, investors and financial media to a Capital Markets Day on Thursday 16 December 2021. The Capital Markets Day will be held at Bond in Helio at Grev Turegatan 30 (Financial Hearings) in Stockholm, Sweden. The meeting starts at 1:00 p.m. and is expected to last until 3:00 p.m., followed by a mingle. The purpose of the Capital Markets Day is to provide an update of the current development in NOTE by CEO and President Johannes Lind-Widestam. In addition, Martin Deas, Managing Director of NOTE's latest acquisition, British iPRO, will provide a description

Sedana Medical submits IND for US clinical trials

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announces that the company has submitted an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA), with the aim to commence its phase III pivotal clinical trials with its Sedaconda products in the United States.Sedana Medical is aiming for a combination registration of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane) for inhaled sedation of mechanically ventilated patients in intensive care. Provided that the IND is approved, the company is planning to commence patient

GlobalConnect Sweden acquires leading communications operator and fiber assets from Telenor Sweden – rapidly growing existing business area and its FTTH footprint

GlobalConnect Sweden has reached an agreement with Telenor Sweden, to acquire communications operator Open Universe and Telenor Sweden’s SDU fiber assets. The acquisition includes approximately 200,000 connected homes on Open Universe’s platform and 14,000 connected homes in Telenor Sweden’s SDU fiber infrastructure. The transaction supports GlobalConnect’s ambitions to bridge digital divide and promote social inclusion across Sweden. The purchase price amounts to SEK 3 billion.GlobalConnect Sweden will continue to build on Open Universe’s robust platform and business model, keeping the

ABS Approves 3D Printed Spare Parts After Successful Testing on an Oil Tanker

ABS, ConocoPhillips Polar Tankers, Sembcorp Marine and 3D Metalforge complete landmark “additive manufacturing” project(SINGAPORE) ABS, ConocoPhillips Polar Tankers, Sembcorp Marine Ltd and 3D Metalforge have taken a significant step to make additive manufacturing (AM) - also known as 3D printing - a reality in the marine industry through a joint development project. Parts fabricated by AM and installed on an oil tanker six months ago have been validated to be in good working condition. This pioneering AM project started in February 2021 with the fabrication and lab-testing of functional

InDex Pharmaceuticals Holding AB (publ) interim report January – September 2021

Ready to initiate patient recruitment in phase III study CONCLUDE”We have now several clinics activated in the phase III study CONCLUDE and look forward to enrol the first patient in the near term”, says Peter Zerhouni, CEO of InDex Pharmaceuticals. ”It was quite dramatic in September when the FDA updated their safety warnings for JAK inhibitors as a class. It is a reminder that a product’s safety profile is very important.” Period July – September 2021 · Net sales amounted to SEK 0.0 (0.0) million · Operating loss amounted to SEK –28.2 (–7.7) million · Result after tax

Proact Chairperson Eva Elmstedt declines re-election

The nomination committee of Proact IT Group AB has initiated its work for the upcoming Annual General Meeting. In connection with this, the Chairperson of the Board, Eva Elmstedt, has informed the nomination committee that she will not be available for re-election at the 2022 Annual General Meeting.Eva Elmstedt has been a member of the Board of Proact IT Group AB since 2009 and has been the Chairperson of the Board since 2018. ”We want to extend a big thank you to Eva for her excellent work, first for nine years as a Board member and for the last four years as the Chairperson of Proact.

Skanska invests EUR 23M, about SEK 230M in a commercial development property in Espoo, Finland

Skanska has acquired a development property in Espoo, Finland. The seller is MSD Finland Oy and the investment amounts to EUR 23M, about SEK 230M.The property encompasses 4,600 square meters of office space and 180 parking places. The property also has over 3,000 square meters of unused building right. After the acquisition Skanska aims to refurbish the existing office building and develop new office premises on the property. The property is in ever-developing Keilaniemi, which has a prime location by the sea with excellent transport connections. The area is known as an innovation and

OX2 acquires rights to 70 MW wind power project in Sweden from RWE Renewables Sweden

OX2 has agreed to acquire from RWE Renewables Sweden the rights to build the Riberget wind farm in the municipality of Ljusdal, Gävleborgs County, Sweden.Under the agreement, OX2 will acquire 100 percent of the project. It comprises 12 turbines and has an estimated capacity of approximately 70 MW. The wind farm holds a legally binding permit and will be an addition to OX2’s Swedish project development portfolio for late-stage onshore wind power. – We are looking forward to working alongside landowners, residents, and the municipality. When OX2 establishes wind farms, we always strive to

Inhalation Sciences Sweden AB (publ) releases Q3 Report 2021

(Stockholm, Sweden, 24 November, 2021) Inhalation Sciences AB announces that the company's Q3 Report for 2021 (in Swedish) is now available on the company's website. For more information please visit: http://inhalation.se/investors/finansiella-rapporter/Summary of the interim report The clinical trial of PreciseInhale is ongoing and on schedule. ISAB expects to be able to present final results and a basis for publishing data within the coming months. This quarter the company has signed several large orders with both new and returning customers. The company had an order backlog of SEK

Innovation from myFC approved by the European Patent Office – electrochemically operated valves optimize fuel cells

The European Patent Office announces that myFC has one of its patents approved in several countries. With the help of the electrochemically operated valve that the patent protects, it is possible to distribute the hydrogen gas individually to the fuel cells.– It enables a cost-effective, individually adapted and more gentle operation, and provides better overall efficiency, says Sebastian Weber, technical manager at myFC.When operating a system consisting of a plurality of fuel cells, combined in so-called FCAs (Fuel Cell Assembly), a common flow of hydrogen gas is distributed to the

Musti Group plc – Managers' transactions – Laurila

Musti Group plc – Managers' transactions – Laurila Musti Group plc            Managers’ transactions                  24 November 2021, at 9.00 a.m. Musti Group Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Laurila Ilkka Position: Member of the Board/Deputy member (X) Legal person Issuer: Musti Group Oyj LEI: 743700IE9NQGF9YZAI97 Notification type: INITIAL NOTIFICATION Reference number: 743700IE9NQGF9YZAI97_20211123113641_3 ____________________________________________

Hans-Jørgen Wibstad resigns as CFO in Multiconsult ASA

Multiconsult ASA (OSE: MULTI)Hans-Jørgen Wibstad has submitted his notice of resignation as CFO in Multiconsult ASA to take the position as CFO in Norwegian Air Shuttle ASA. The search for a new CFO will commence immediately. Wibstad will continue in his role and will leave the company no later than 31 May 2022.“I would like to thank Hans-Jørgen for his strong contribution and dedication to Multiconsult. Since joining Multiconsult in May 2019, he has played a key role in the transformation and improvement processes that have taken place in Multiconsult. While we regret his decision, we

Warrants of series TO1 were subscribed to approximately 96.24 percent corresponding to approximately SEK 16.85 million

Realfiction Holding AB (”Realfiction” or the ”Company”) today announces the outcome of the exercise of warrants of series TO1, which were issued in connection with the Company’s directed issue during the fourth quarter of 2020. In total, 1,470,405 warrants of series TO1 were exercised, corresponding to approximately 96.24 percent of the total number of outstanding warrants of series TO1, for subscription of 1,470,405 shares at a subscription price of SEK 11.46 per share. Realfiction will receive approximately SEK 16.85 million before issuing costs through the exercise of the warrants of

Oncopeptides publishes Q3 2021 report

Back to the futureSTOCKHOLM — November 24, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, has today published the report for the third quarter 2021. Financial overview July-September · Net sales amounted to SEK 54.3 M (0.0) · Operating loss amounted to SEK 338.9 M (loss: 383.5) · Loss for the period was SEK 777.5 M (loss: 383.4) · Loss per share, before and after dilution, was SEK 10.33 (loss: 5.71) · Cash and cash equivalents amounted to SEK 671.3 M (

There are no items matching the current filter
There are no more items matching the current filter
Back to top